Rigel Pharmaceuticals Discusses VEPPANU Licensing Agreement on M&A Call

Rigel Pharmaceuticals held a conference call on May 12, 2026 to discuss a VEPPANU licensing agreement,…

IDEAYA Biosciences Discusses Strategy and Clinical Pipeline at Bank of America Healthcare Conference 2026

IDEAYA Biosciences participated in the Bank of America Global Healthcare Conference 2026, placing the clinical-stage biotech…